New pill may help keep aggressive colon cancer at bay after surgery
NCT ID NCT07405736
Summary
This study is testing if adding a drug called lubiprostone to standard follow-up care can help prevent cancer from returning in people who had surgery for colorectal cancer that had spread to the abdominal lining. About 124 participants will be randomly assigned to receive either the standard care alone or standard care plus lubiprostone. Researchers will track if the added drug helps people stay cancer-free longer and improves their quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER (CRC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.